Pendulum Therapeutics
Pendulum Therapeutics is a biotechnology company founded in 2013 that focuses on microbiome science. The company develops innovative probiotic formulations aimed at supporting metabolic health. Led by CEO Colleen Cutcliffe, who has a Ph.D. in Biochemistry and Molecular Biology, Pendulum is dedicated to improving lives through microbiome-targeted medical probiotics. The company offers a range of products designed to enhance metabolic health and gut wellness, including Pendulum Glucose Control, the first medical probiotic clinically proven to improve A1C levels in individuals with type 2 diabetes. Other products include Akkermansia, a novel probiotic strain, Metabolic Daily for metabolism support, and Polyphenol Booster to increase antioxidants. Pendulum Therapeutics is recognized for its commitment to research and innovation, partnering with institutions like the Mayo Clinic to advance microbiome research. The company has received strategic investments to enhance its offerings and is endorsed by health professionals, making its products available through various retail channels.
Work at Pendulum Therapeutics in HR or recruiting? Claim this page
Headcount trend
Pendulum Therapeutics went from 76 employees in Jul 2023 to 113 in Jun 2025. Jan to Jun 2025: 14 people joined, 11 left.
Headcount data through Jun 2025
Org structure
Headcount by department
H-1B sponsorship
Funding
- Jun 2023 · $10M · Fonterra Co-operative Group Limited
- Apr 2021 · Series C · $54M · Meritech Capital, Seqouia Capital, True Ventures
- May 2019 · Series B · $35M · Seqouia Capital, True Ventures, Khosla Ventures
- Jun 2017 · Series A · $18.5M · True Ventures, Khosla Ventures
- Dec 2014 · Seed · $3.5M · True Ventures, Felicis Ventures
Peer reviews
Worked with someone at Pendulum Therapeutics?
Anonymous peer reviews on OffTheRecord
Similar companies
Pendulum Therapeutics FAQ
How many employees does Pendulum Therapeutics have?
Pendulum Therapeutics has about 113 employees, up 0.9% over the 3 months to Jun 2025.
Does Pendulum Therapeutics sponsor H1B visas?
Yes. Pendulum Therapeutics filed 1 H1B (LCA) application in FY2025, according to the latest U.S. Department of Labor disclosures. It was for a Engineering role.
What is Pendulum Therapeutics's revenue per employee?
Pendulum Therapeutics makes about $27K in revenue per employee, based on $3M annual revenue and 113 employees.
How much funding has Pendulum Therapeutics raised?
Pendulum Therapeutics has raised $121M in total funding.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.
